CARDINAL HEALTH INC (CAH:NYSE)
$234.57 -1.45 (-0.6144%)
Analysed CARDINAL HEALTH INC (CAH:NYSE) News Sources
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
11-09-2026
fool.com
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
11-09-2026
fool.com
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
11-09-2026
yahoo.com
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
08-09-2026
marketbeat.com
Is Generics Still a Quiet Profit Engine for Cardinal Health?
03-09-2026
yahoo.com
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”
03-09-2026
yahoo.com
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
08-09-2026
yahoo.com
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
08-09-2026
yahoo.com
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
09-09-2026
yahoo.com
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?
10-09-2026
yahoo.com
What is the current price of CARDINAL HEALTH INC (CAH:NYSE)?
The current price of CARDINAL HEALTH INC (CAH:NYSE) is $234.57.
CARDINAL HEALTH INC (CAH:NYSE) absolute price change since previous trading day?
The absolute price change of CARDINAL HEALTH INC (CAH:NYSE) since the previous trading day is $-1.45.
CARDINAL HEALTH INC (CAH:NYSE) percentage price change since previous trading day?
The percentage price change of CARDINAL HEALTH INC (CAH:NYSE) since the previous trading day is -0.6144%.
What is the most recent average sentiment score for CARDINAL HEALTH INC (CAH:NYSE)?
The most recent average sentiment score for CARDINAL HEALTH INC (CAH:NYSE) is 69 out of 100.
What is the most recent average sentiment for CARDINAL HEALTH INC (CAH:NYSE)?
The most recent sentiment for CARDINAL HEALTH INC (CAH:NYSE) is .
SEC-8K** Filing Available For CARDINAL HEALTH INC (CAH:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.